Increasing Public Health Awareness Intensifies Global Uptake of Autoimmune...
MOUNTAIN VIEW Calif. Sept. 26 2013 PRNewswire &160;Successful autoimmune disease awareness campaigns are encouraging patients to seek clinical diagnostics even for general symptoms such as fatigue...
View ArticleDiet Therapy Appears to Induce Remission in Some With Biologicsresistant Crohns
Some Crohns disease CD patients who are not helped by biologics go into remission when treated with diet alone new research shows. Reuters Health Information
View ArticleOne Million People Living With Chronic Conditions Now Rely On MyHealthTeams
SAN FRANCISCO June 12 2017 PRNewswire MyHealthTeams has closed its Series C financing round which will accelerate the company's leadership in patient engagement among those living with chronic...
View ArticleJanssen's Stelara overtakes Takeda's Entyvio as the leading alternative MOA...
EXTON Pa. June 13 2017 PRNewswire Spherix Global Insights announces the release of RealWorld Dynamix Biologic Switching in IBD which engaged 187 gastroenterologists to conduct an indepth review of over...
View ArticleUpdate Belgian Stem Cell Therapy Closer to Market with Phase III Launch
Update 07062017 TiGenix has announced the official launch of the Phase III trial that will support the approval of Cx601 a stem cell therapy for Crohn&8217;s disease. Originally published on...
View ArticleRedHill Biopharma Initiates Promotion of Donnatal and EnteraGam in the U.S.
RedHill has initiated commercial activities in the U.S. with its gastrointestinalfocused sales force promoting two gastrointestinal specialty products Donnatal and EnteraGam TelAviv Israel Raleigh NC...
View ArticleResults from CRIB study on CIMZIAÂ certolizumab pegol demonstrate minimal to...
BRUSSELS June 13 2017 PRNewswire UCB today presented results from CRIB a pharmacokinetic study designed to assess if CIMZIAÂ certolizumab pegol is transferred across the placenta from pregnant women to...
View ArticleTiGenix initiates Phase III trial of Cx601 to treat perianal fistulas
Belgiumbased biopharmaceutical firm TiGenix has marked the initiation of a Phase III clinical trial of Cx601 for the treatment of complex perianal fistulas in Crohn's disease patients with its first...
View ArticleArena Pharmaceuticals Appoints Jennifer Jarrett to Board of Directors
SAN DIEGO June 14 2017 PRNewswire Arena Pharmaceuticals Inc. NASDAQ ARNA today announced the appointment of Jennifer Jarrett to the Company's Board of Directors. Ms. Jarrett has over 20 years of...
View ArticleCrohn's Disease Forecast in 8 Major Markets 20162026 Updated 15012016 Prices...
Black Swan Analysis Epiomic Epidemiology Series Forecast Report on Crohn's Disease in 8 Major MarketsCrohn's disease also known as regional enteritis is a type of chronic inflammatory bowel disease....
View ArticleUlcerative Colitis Forecast in 8 Major Markets 20162026 Updated 01022016...
Black Swan Analysis Epiomic Epidemiology Series Forecast Report on Ulcerative Colitis in 8 Major MarketsUlcerative Colitis UC is an inflammatory bowel disease IBD causing chronic inflammation in the...
View ArticleChronic Hepatitis C Forecast in 12 Major Markets 20172027 Updated 01012017...
Black Swan Analysis Epiomic Epidemiology Series Forecast Report on Chronic Hepatitis C in 12 Major MarketsHepatitis C is a singlestranded RNA virus that infects and damages the liver. In most cases...
View ArticleMyasthemia Gravis Forecast in 26 Major Markets 20172027 Updated 01042017...
Black Swan Analysis Epiomic Epidemiology Series Forecast Report on Myasthenia Gravis in 26 Major MarketsMyasthenia Gravis MG also known as autoimmune myasthenia is one of the most significant diseases...
View ArticleFrost Miller Tapped for CrohnÂÂs and Colitis CongressTM Promotion
Bethesda MD PRWEB June 15 2017 Frost Miller has been hired to provide marketing support for the firstever CrohnÂÂs and Colitis CongressÂÂ developed through a partnership of the CrohnÂÂs ...
View ArticleRedHill Biopharma Announces Successful Phase III TopLine Results with...
The positive Phase III topline results indicate that the study successfully met its primary endpoint and BEKINDAÂ 24 mg was shown to be effective safe and well tolerated in patients with acute...
View ArticleGlobal Immunology Drugs Market to 2022 Increasing Prevalence Repositioning...
Global Immunology Drugs Market to 2022 Increasing Prevalence Repositioning Opportunities and Strong Uptake of Interleukin Receptor Inhibitors to Drive GrowthSummaryImmunology is a therapy area...
View ArticleToll Like Receptor 8 CD288 or TLR8 Pipeline Review H1 2017 Updated 13062017...
Toll Like Receptor 8 CD288 or TLR8 Pipeline Review H1 2017SummaryToll Like Receptor 8 CD288 or TLR8 Tolllike receptor 8 is a protein encoded by the TLR8 gene. It control host immune response against...
View ArticleProtein Phosphatase 2A PP2A or EC 3.1.3.16 Pipeline Review H1 2017 Updated...
Protein Phosphatase 2A PP2A or EC 3.1.3.16 Pipeline Review H1 2017SummaryAccording to the recently published report 'Protein Phosphatase 2A Pipeline Review H1 2017'; Protein Phosphatase 2A PP2A or EC...
View ArticleTyrosine Protein Kinase Fyn Proto Oncogene Syn or Proto Oncogene c Fyn or Src...
Tyrosine Protein Kinase Fyn Proto Oncogene Syn or Proto Oncogene c Fyn or Src Like Kinase or p59 Fyn or FYN or EC 2.7.10.2 Pipeline Review H1 2017SummaryAccording to the recently published report...
View ArticleArena Pharmaceuticals Announces Shareholders and Board of Directors Approve...
SAN DIEGO June 14 2017 PRNewswire Arena Pharmaceuticals Inc. NASDAQ ARNA today announced that at the annual meeting of stockholders held June 13 2017 stockholders voted to approve a proposal...
View Article